256 related articles for article (PubMed ID: 26239979)
41. Kanamycin susceptibility testing of Mycobacterium tuberculosis using Mycobacterium Growth Indicator Tube and a colorimetric method.
Bastian I; Rigouts L; Palomino JC; Portaels F
Antimicrob Agents Chemother; 2001 Jun; 45(6):1934-6. PubMed ID: 11353658
[TBL] [Abstract][Full Text] [Related]
42. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium.
Collins L; Franzblau SG
Antimicrob Agents Chemother; 1997 May; 41(5):1004-9. PubMed ID: 9145860
[TBL] [Abstract][Full Text] [Related]
43. Rapid evaluation in whole blood culture of regimens for XDR-TB containing PNU-100480 (sutezolid), TMC207, PA-824, SQ109, and pyrazinamide.
Wallis RS; Jakubiec W; Mitton-Fry M; Ladutko L; Campbell S; Paige D; Silvia A; Miller PF
PLoS One; 2012; 7(1):e30479. PubMed ID: 22279595
[TBL] [Abstract][Full Text] [Related]
44. Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis.
Sala C; Dhar N; Hartkoorn RC; Zhang M; Ha YH; Schneider P; Cole ST
Antimicrob Agents Chemother; 2010 Oct; 54(10):4150-8. PubMed ID: 20679505
[TBL] [Abstract][Full Text] [Related]
45. Activity of Moxifloxacin against
Louie A; Duncanson B; Myrick J; Maynard M; Nole J; Brown D; Schmidt S; Neely M; Scanga CA; Peloquin C; Drusano GL
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249693
[TBL] [Abstract][Full Text] [Related]
46. Prevention of drug carryover effects in studies assessing antimycobacterial efficacy of TMC207.
Lounis N; Gevers T; Van Den Berg J; Verhaeghe T; van Heeswijk R; Andries K
J Clin Microbiol; 2008 Jul; 46(7):2212-5. PubMed ID: 18480227
[TBL] [Abstract][Full Text] [Related]
47. Respiratory flexibility in response to inhibition of cytochrome C oxidase in Mycobacterium tuberculosis.
Arora K; Ochoa-Montaño B; Tsang PS; Blundell TL; Dawes SS; Mizrahi V; Bayliss T; Mackenzie CJ; Cleghorn LA; Ray PC; Wyatt PG; Uh E; Lee J; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2014 Nov; 58(11):6962-5. PubMed ID: 25155596
[TBL] [Abstract][Full Text] [Related]
48. Antibacterial and Sterilizing Effect of Benzylpenicillin in Tuberculosis.
Deshpande D; Srivastava S; Bendet P; Martin KR; Cirrincione KN; Lee PS; Pasipanodya JG; Dheda K; Gumbo T
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29180526
[TBL] [Abstract][Full Text] [Related]
49. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB
J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154
[TBL] [Abstract][Full Text] [Related]
50. Identification of novel inhibitors of nonreplicating Mycobacterium tuberculosis using a carbon starvation model.
Grant SS; Kawate T; Nag PP; Silvis MR; Gordon K; Stanley SA; Kazyanskaya E; Nietupski R; Golas A; Fitzgerald M; Cho S; Franzblau SG; Hung DT
ACS Chem Biol; 2013 Oct; 8(10):2224-34. PubMed ID: 23898841
[TBL] [Abstract][Full Text] [Related]
51. A Multistress Model for High Throughput Screening Against Nonreplicating Mycobacterium tuberculosis.
Gold B; Warrier T; Nathan C
Methods Mol Biol; 2021; 2314():611-635. PubMed ID: 34235673
[TBL] [Abstract][Full Text] [Related]
52. In vitro activity of bedaquiline against slow-growing nontuberculous mycobacteria.
Martin A; Godino IT; Aguilar-Ayala DA; Mathys V; Lounis N; Villalobos HR
J Med Microbiol; 2019 Aug; 68(8):1137-1139. PubMed ID: 31210631
[TBL] [Abstract][Full Text] [Related]
53. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay.
Jadaun GP; Agarwal C; Sharma H; Ahmed Z; Upadhyay P; Faujdar J; Gupta AK; Das R; Gupta P; Chauhan DS; Sharma VD; Katoch VM
J Antimicrob Chemother; 2007 Jul; 60(1):152-5. PubMed ID: 17483147
[TBL] [Abstract][Full Text] [Related]
54. Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis.
Early J; Ollinger J; Darby C; Alling T; Mullen S; Casey A; Gold B; Ochoada J; Wiernicki T; Masquelin T; Nathan C; Hipskind PA; Parish T
ACS Infect Dis; 2019 Feb; 5(2):272-280. PubMed ID: 30501173
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the BACTEC MGIT 960 system and the resazurin microtiter assay for susceptibility testing of Mycobacterium tuberculosis to second-line drugs.
Gallo JF; Pinhata JMW; Saraceni CP; de Oliveira RS
J Microbiol Methods; 2017 Aug; 139():168-171. PubMed ID: 28601653
[TBL] [Abstract][Full Text] [Related]
56. Determination of compound kill kinetics against Mycobacterium tuberculosis.
Early J; Alling T
Methods Mol Biol; 2015; 1285():269-79. PubMed ID: 25779322
[TBL] [Abstract][Full Text] [Related]
57. Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.
Lenaerts AJ; Gruppo V; Marietta KS; Johnson CM; Driscoll DK; Tompkins NM; Rose JD; Reynolds RC; Orme IM
Antimicrob Agents Chemother; 2005 Jun; 49(6):2294-301. PubMed ID: 15917524
[TBL] [Abstract][Full Text] [Related]
58. Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis.
Volynets GP; Tukalo MA; Bdzhola VG; Derkach NM; Gumeniuk MI; Tarnavskiy SS; Starosyla SA; Yarmoluk SM
J Antibiot (Tokyo); 2019 Apr; 72(4):218-224. PubMed ID: 30662064
[TBL] [Abstract][Full Text] [Related]
59.
Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
[TBL] [Abstract][Full Text] [Related]
60. Combinations of Respiratory Chain Inhibitors Have Enhanced Bactericidal Activity against Mycobacterium tuberculosis.
Berube BJ; Parish T
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
